Jan 13, 2025 11:16 Lupin Gets USFDA Approval for Generic Cystic Fibrosis Treatment Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis.

Below are some trading ideas for the near term: After the short-term correction from higher levels, the downward momentum in Lupin has stopped around its support area. On the daily charts ...

Vanzacaftor-tezacaftor-deutivacaftor, a novel therapeutic, once-daily drug, demonstrates noninferiority to elexacaftor-tezacaftor-ivacaftor (the twice-daily, standard-of-care drug) in lung ...

Lupin is an innovation led Transnational Pharmaceutical Company producing developing and marketing a wide range of branded & generic formulations biotechnology products and active pharmaceutical ...

Axis Securities recommends an overweight call on Lupin with a target price of Rs 2600. Lupin's current price is Rs 2160. New launches in the US are expected to boost sales. Recent approvals have ...

Security Information and Event Management (SIEM) systems are now a critical component of enterprise security. Learn more from Smarttech247 about how its VisionX + Splunk solution can help secure ...

Dec. 26, 2024 — Bio-inspired wind sensing using strain sensors on flexible wings could revolutionize robotic flight control strategy. Researchers have developed a method to detect wind direction ...

Jan. 23, 2025 — Researchers have uncovered which genes on the Y chromosome regulate the development of sperm and impact fertility in male mice. This research could help us understand why some ...

Ukrainian forces described a different kind of enemy, fighting with unfamiliar tactics and little option to retreat. By Marc Santora and Helene Cooper Rupert Murdoch’s News Group Newspapers ...

Trump Officials Move to Quickly Expel Migrants Biden Allowed In Temporarily A memo appears to allow Immigration and Customs Enforcement officials to target Biden-era programs that let in more than ...